Scientists Report a Blood Biomarker That Could Allow Diagnosis of CTE in Living Patients, Opening a Path to Detecting the Brain Disease
Scientists have reported a blood biomarker that could allow chronic traumatic encephalopathy, or CTE, to be diagnosed in living patients. CTE is a degenerative brain condition that is common in contact sports such as rugby and American football. The researchers are optimistic that the finding is a significant step. CTE can now be confirmed only after death. The report was published Nov. 14.
A blood test would let doctors identify the condition in living people, which could change how athletes and veterans with head injuries are monitored. A biomarker is a measurable sign in the body; to be useful it must be shown to be accurate across large groups, not only in early studies.
If you or a child plays a contact sport, the practical steps remain the same for now: report concussion symptoms, avoid returning to play before clearance and follow league head-injury rules. A blood test for CTE is not available to the public yet.
One view is that a blood marker could make CTE research faster and give athletes an early warning.
Another view is that early findings often shrink in larger studies, and a test that cannot be acted on with a treatment could cause worry without benefit.
Reported: scientists found a blood biomarker that may point to CTE in living patients. Not shown: that it works as a routine test or that any treatment follows. This rests on one report; watch for the study itself and independent reviews.
DailyDrop U.S. No. 41 · November 14, 2026